Evidence map›Paper›PMID 30482917›Full record

ArticleNature neuroscience2019

Publisher Correction: Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease.

Xianjun Dong, Zhixiang Liao, David Gritsch, Yavor Hadzhiev, Yunfei Bai, Joseph J Locascio, Boris Guennewig, Ganqiang Liu, Cornelis Blauwendraat, Tao Wang and 12 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Xianjun DongPrecision Neurology Program, Harvard Medical School and Brigham & Women's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-8052-9320
Zhixiang LiaoPrecision Neurology Program, Harvard Medical School and Brigham & Women's Hospital, Boston, MA, USA.
David GritschPrecision Neurology Program, Harvard Medical School and Brigham & Women's Hospital, Boston, MA, USA.
Yavor HadzhievInstitute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.ORCID http://orcid.org/0000-0002-1134-4904
Yunfei BaiPrecision Neurology Program, Harvard Medical School and Brigham & Women's Hospital, Boston, MA, USA.
Joseph J LocascioPrecision Neurology Program, Harvard Medical School and Brigham & Women's Hospital, Boston, MA, USA.
Boris GuennewigSydney Medical School, Brain and Mind Centre, The University of Sydney, Sydney, New South Wales, Australia.
Ganqiang LiuPrecision Neurology Program, Harvard Medical School and Brigham & Women's Hospital, Boston, MA, USA.
Cornelis BlauwendraatGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Tao WangPrecision Neurology Program, Harvard Medical School and Brigham & Women's Hospital, Boston, MA, USA.
Charles H AdlerDepartment of Neurology, Mayo Clinic, Scottsdale, AZ, USA.
John C HedreenHarvard Brain Tissue Resource Center, McLean Hospital, Harvard Medical School, Boston, MA, USA.
Richard L M FaullCentre for Brain Research, University of Auckland, Auckland, New Zealand.
Matthew P FroschC.S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital, Boston, MA, USA.
Peter T NelsonSanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Patrizia RizzuGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Antony A CooperDivision of Neuroscience, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
Peter HeutinkGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.ORCID http://orcid.org/0000-0001-5218-1737
Thomas G BeachBanner Sun Health Research Institute, Sun City, AZ, USA.
John S MattickDivision of Neuroscience, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.ORCID http://orcid.org/0000-0002-7680-7527
Ferenc MüllerInstitute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.ORCID http://orcid.org/0000-0002-0996-774X
Clemens R ScherzerPrecision Neurology Program, Harvard Medical School and Brigham & Women's Hospital, Boston, MA, USA. cscherzer@rics.bwh.harvard.edu.ORCID http://orcid.org/0000-0002-0567-9193

Funding

University of Kentucky Alzheimer's Disease Core Center - Biomarker CoreP30AG028383 · NIA · UNIVERSITY OF KENTUCKY · PI SCHMITT, FREDERICK · 2006 to 2020
$23.3M
NIA NIH HHS P30 AG028383
6 · The paper itself

Abstract

In the version of this article initially published, the legends for Supplementary Figs. 4-8 and 10-14 contained errors. The Supplementary Figure legends have been corrected in the HTML and PDF versions of the article.

Identifiers

PMID30482917

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.